This inventor holds 27 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Biotechnology. Top assignees: Zymogenetics, Inc., University of Washington. Active years: 2007-2017.
Location History:
- Brier, WA (US) (2008 - 2009)
- Seattle, WA (US) (2007 - 2017)
Company Filing History:
Years Active: 2007-2017
Areas of Expertise:
Title: Innovations and Contributions of Hong Yan Liu
Introduction
Hong Yan Liu, based in Seattle, WA, has made significant contributions to the field of biotechnology and molecular biology, being credited with an impressive portfolio of 27 patents. His work primarily focuses on the delivery and production of therapeutic proteins and nucleic acids, showcasing his innovative approach to solving complex biological challenges.
Latest Patents
Among his latest patents is the "Universal Protein Tag for Double Stranded Nucleic Acid Delivery." This invention introduces chimeric proteins that incorporate double stranded nucleic acid binding domains and polyHis domains. The compositions described aim to enhance the targeted delivery of therapeutic double stranded nucleic acids for disease treatment.
Another notable patent is related to "FGF18 Production in Prokaryotic Hosts." This patent outlines expression vectors and methods for the large-scale production of FGF18. Liu's innovative approach optimizes the codons and mRNA secondary structure, achieving impressive production levels exceeding 1 g/L in fed batch fermentation. This advancement has the potential to impact the pharmaceutical industry significantly.
Career Highlights
Hong Yan Liu has gained valuable experience in several prestigious organizations, including Zymogenetics, Inc. and the University of Washington through its Center for Commercialization. His work in these institutions has facilitated advancements in biotechnology, particularly in the production and application of therapeutic proteins.
Collaborations
Throughout his career, Liu has partnered with prominent colleagues such as Lowell J. Brady and Kevin M. Klucher. These collaborations have fostered innovative ideas and contributed to the successful development of his patents, further demonstrating the impact of teamwork in scientific research and invention.
Conclusion
Hong Yan Liu exemplifies the spirit of innovation in biotechnology, as evidenced by his extensive patent portfolio and collaborations with industry leaders. His contributions to the fields of protein delivery and production continue to pave the way for novel therapeutic solutions, ultimately benefiting the landscape of modern medicine.